Hereditary kidney cancer: unique opportunity for disease-based therapy. - Wikidata - awgldk - TriplyDB

Hereditary kidney cancer: unique opportunity for disease-based therapy.

Hereditary kidney cancer: unique opportunity for disease-based therapy.

http://www.wikidata.org/entity/Q37287088

about

Renal cell carcinoma: Evolving and emerging subtypes Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3 Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.Non-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches.The changing face of renal-cell carcinoma.Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives.Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC Fnip1 regulates skeletal muscle fiber type specification, fatigue resistance, and susceptibility to muscular dystrophy.Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype.Biology of metastatic renal cell carcinoma.Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancer Metastatic non-clear cell renal cell carcinoma: an evidence based review of current treatment strategies Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23 The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma.Dysfunctional miRNA-Mediated Regulation in Chromophobe Renal Cell Carcinoma Decreasing the indications for radical nephrectomy: a study of multifocal renal cell carcinoma.MET as a possible target for non-small-cell lung cancer.Canadian guideline on genetic screening for hereditary renal cell cancers Hereditary kidney cancer syndromes.Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome Genetic profiles in renal tumors.Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy.Misdiagnosis of clear cell renal cell carcinoma.Sequential therapy in metastatic clear cell renal carcinoma: TKI-TKI vs TKI-mTOR.Foretinib (XL880): c-MET inhibitor with activity in papillary renal cell cancer.PBRM1 and BAP1 as novel targets for renal cell carcinoma Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.Pathology, therapy and prognosis of papillary renal carcinoma.Renal cell carcinoma: new insights and challenges for a clinician scientist.Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.A common variant at 8q24.21 is associated with renal cell cancer.

P2860

Q24629153-A21B358A-EACD-4A2E-B8E6-1E00CA8CB840 Q28943264-A36FF78E-73B8-430D-9BBD-C219EBB7C6C9 Q28943459-0AF6CE8B-7574-4757-9356-C8789557967E Q30277177-715E1E76-AA18-4F38-BB02-BB1894CD89ED Q34194075-D0586578-D468-4F65-B06B-7EFDB9868D17 Q34246490-C80DFD20-0975-4A04-B363-23A28D85945A Q34351372-7A24D500-D540-4B33-8346-3DD7E018C145 Q34637666-DD84CF68-D3D2-42DB-A1EB-0176075DDE0C Q34663243-5400C99A-861E-45D2-9CB0-0FB0346443FC Q34985419-65630566-A2FA-4B16-8D66-166B50EC5900 Q35006347-D8EF1A66-481C-46D6-882F-3C763F982512 Q35167463-9DC3FD5D-DA31-48A0-841F-E009C8742670 Q35235259-02E80EBB-A61E-4AFC-897E-4846907648F2 Q35315403-E2B94542-9BC5-4C20-BC30-99D898658BE8 Q35641254-CFE4E7C5-E64E-499F-ADBF-E323A0001447 Q35747147-BEDDDC1A-552B-4922-A6BD-7259B716E31C Q35750240-067959E2-E13F-4078-81E2-B56213CA6B95 Q36039914-FB915886-D8F3-48CE-9292-B5C152D6B02C Q36141563-D17D1F2D-B8EB-4507-8BF8-FF3D41F7A8CC Q36660673-E1DC8357-942C-48AB-91E4-C47523BA2C22 Q37371645-54BEB772-5FEF-4273-BAC7-04F4EC55EC48 Q37412363-2E278934-F940-4278-9159-9C9105AE8202 Q37572095-BF04D225-8AC9-4415-8036-E01EBC379493 Q37615533-DCCC04C1-1667-4EB6-8DD9-82B856349596 Q37765586-23FE7D5D-3E7C-46E9-8D6B-E9E62CDB0102 Q37876683-E4D378D4-6F33-4FF1-A3CD-7C0B4EF260C3 Q38068584-0523C5B0-9EBD-4475-A3CC-F4B892801956 Q38081379-21F6ABE7-FF01-4EDC-8DF7-C57248DCACC1 Q38122565-0DFCC6D2-9194-49D4-8DEE-2C3949898EBC Q38264616-6E0C6FAE-31E6-4AB6-BC4D-1DFC28ECD6E2 Q38312048-7C9D1CBC-42B4-4928-8463-CD2FC1F13B33 Q39222755-20AEF127-34F3-4496-AB6E-6025E75C2FDB Q39604051-3232F6CD-3C7F-4D40-936A-7FAFA25FFBAD Q54616047-7E9F39E3-A2D7-4CF3-B283-A8E3EA20ABBC

P2860

Hereditary kidney cancer: unique opportunity for disease-based therapy.

http://www.wikidata.org/entity/Q37287088

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Hereditary kidney cancer: unique opportunity for disease-based therapy.

@en

Hereditary kidney cancer: unique opportunity for disease-based therapy.

@nl

type

label

Hereditary kidney cancer: unique opportunity for disease-based therapy.

@en

Hereditary kidney cancer: unique opportunity for disease-based therapy.

@nl

prefLabel

Hereditary kidney cancer: unique opportunity for disease-based therapy.

@en

Hereditary kidney cancer: unique opportunity for disease-based therapy.

@nl

P1433

Q37287088-CED63AD8-2A1B-4DDB-AB49-EF4FC65C60DB

P1476

Q37287088-ABB67D8D-C546-4817-8A3D-AA54D50AC2EF

P2093

Q37287088-0724D6B1-73C4-42AA-98D2-6FF558D3B3AA

Q37287088-25249A9E-C83C-4672-ABEA-476F8A884FDC

Q37287088-326D069B-9BCF-4D71-A219-53750B873D51

Q37287088-3BD7BB0C-8F3F-40BB-A8B3-556EE8B832BA

Q37287088-633CC8EE-8ADE-4DDB-A250-493DCAB86817

Q37287088-8F786FD4-146E-4922-9301-A1EDA62D0A67

Q37287088-A5C47E6A-C51C-4D9D-94AE-5DE05B1A26B7

Q37287088-CC5FA55B-C6B4-491D-9FCA-5D0CF0F5628E

Q37287088-D7CFECAC-88C1-465A-B4A4-24FE0191DC3A

Q37287088-E9856E02-2770-4C15-8661-650F4AB88A81

P2860

Q37287088-040F4F66-8616-425D-8991-3349D2A07F10

Q37287088-067D63D8-954F-4754-A1F0-17B168775138

Q37287088-094E7DAB-825C-45C5-980F-9ACE8CF8632D

Q37287088-0B7757D9-A684-4D81-B46A-FD1E48043AE0

Q37287088-0CD57D70-AE97-44AB-B54A-AF993BA4E260

Q37287088-0FCF7227-E581-4F32-81A8-3DAE1E22768C

Q37287088-1AB225B7-3E28-4EF9-92EA-0463BDCBC1FA

Q37287088-1AEED727-1556-4EAD-B30E-1316519456F4

Q37287088-2DEEF17B-1E21-4834-925D-824AB54E4E86

Q37287088-38F468AE-029A-436E-8B9D-4A9C65406463

P304

Q37287088-EEE70DD0-EBAD-40AD-AE02-C7B85D1178FE

P31

Q37287088-E971A930-1A98-403F-8DD8-4163D6F0DE3A

P356

Q37287088-A6D0A4EB-8719-4AE6-A957-8D013DA47A24

P407

Q37287088-C48BDA90-263D-4CCB-9278-78EBA6D7F3C7

P433

Q37287088-D54D1C1E-653E-4E7F-AAD3-011BE8918883

P478

Q37287088-A1B9F15C-99B4-4736-8922-25ECA83EA527

P50

Q37287088-0EFB1CA3-4768-4691-8A3E-6A6A7B35A4CD

P577

Q37287088-CD5D4732-98E1-4CDB-A475-1890B6F2B78D

P5875

Q37287088-660B27AF-6122-4E2C-9FDF-38488A403615

P698

Q37287088-F36237A3-198F-4DF5-868D-2E683B4483C5

P932

Q37287088-88CF2BD0-CC2D-4F39-A4A5-F522731281F1

P356

P1433

P1476

Hereditary kidney cancer: unique opportunity for disease-based therapy

@en

P2093

Cathy D Vocke

http://www.w3.org/2001/XMLSchema#string

Elizabeth Pfaffenroth

http://www.w3.org/2001/XMLSchema#string

Gennady Bratslavsky

http://www.w3.org/2001/XMLSchema#string

Jorge R Toro

http://www.w3.org/2001/XMLSchema#string

Laura S Schmidt

http://www.w3.org/2001/XMLSchema#string

Len Neckers

http://www.w3.org/2001/XMLSchema#string

Maria Merino

http://www.w3.org/2001/XMLSchema#string

Peter A Pinto

http://www.w3.org/2001/XMLSchema#string

Ramaprasad Srinivasan

http://www.w3.org/2001/XMLSchema#string

W Marston Linehan

http://www.w3.org/2001/XMLSchema#string

P2860

Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling

Identification and characterization of a novel folliculin-interacting protein FNIP2

Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America

Genotype-phenotype correlation in von Hippel-Lindau disease with retinal angiomatosis

Cancer statistics, 2008

von Hippel-Lindau disease

Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Sorafenib in advanced clear-cell renal-cell carcinoma

Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys

P304

2252-2261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.24230

http://www.w3.org/2001/XMLSchema#string

P407

P433

10 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Donald P. Bottaro

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227722516

http://www.w3.org/2001/XMLSchema#string

P698

19402075

http://www.w3.org/2001/XMLSchema#string

P932

2720093

http://www.w3.org/2001/XMLSchema#string